Mavenclad “Now Approved” Page

Apr 2, 2019Apr 3, 2019

Brand: Mavenclad (cladribine), Tablets
Parent Company: EMD Serono
Drug Type: Boxed Warning
Drug Category: Neurology
Campaign: now-approved
Targeting: HCPs
Patient Website:
HCP Website:

: Homepage

: Homepage scroll

: Mobile

The gallery of digital pharma marketing screenshots.

Mavenclad “Now Approved” Page

Your Email

Phone
This field is for validation purposes and should be left unchanged.

We’ll never share or sell your personal info. Ever.